High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference41 articles.
1. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a cancer and leukemia group B study;Becker;J. Clin. Oncol.,2010
2. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data;Bindea;Bioinformatics,2013
3. Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression;Boulay;Cancer Res.,2016
4. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Cancer Genome Atlas Research N;N. Engl. J. Med.,2013
5. Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation;Cetin;Gen. Testing Mol. Biomarkers,2015
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells;Archives of Biochemistry and Biophysics;2023-03
2. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies;Signal Transduction and Targeted Therapy;2023-02-17
3. Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation;International Journal of Molecular Sciences;2023-01-15
4. DNA Methylation Alterations in Acute Myeloid Leukemia: Therapeutic Potential;Interdisciplinary Cancer Research;2023
5. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool;International Journal of Molecular Sciences;2022-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3